Rheumatology Advance Access originally published online on May 30, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2003; 42: 1173-1178
© 2003 British Society for Rheumatology
SACRAH: a score for assessment and quantification of chronic rheumatic affections of the hands
Second Department of Medicine, Humanisklinikum Lower Austria, Lower Austrian Center for Rheumatology, Stockerau, Austria.
Correspondence to:
Drs Leeb and Sautner contributed equally to this paper. Correspondence to: B. F. Leeb, Second Department of Medicine, Humanisklinikum Lower Austria, Lower Austrian Center for Rheumatology, Landstrasse 18, Stockerau, A-2000 Austria. E-mail: leeb.khstockerau{at}aon.at
Objectives. To establish a questionnaire to quantify the extent of the function and activities of the hand in patients with degenerative or inflammatory disease of the hand and finger joints.
Methods. One hundred and seventy-two patients with osteoarthritis (OA, n = 69) or rheumatoid arthritis (RA, n = 103) completed a new questionnaire, the SACRAH, that included 23 visual analogue scales covering the extent of hand function, stiffness and level of pain. SACRAH scores may range from 0 to 100.
Results. Comparing all studied patients, there was no significant difference in SACRAH scores between OA and RA patients (34 vs 32, not significant). Scores for both patient groups differed significantly from those for 30 healthy controls. Among patients taking NSAIDs only, individuals suffering from OA (n = 50) scored significantly lower than RA patients (n = 42) (36 vs 48, P < 0.004). Sixty-one RA patients taking DMARDs scored lower than the RA patient group treated with NSAIDs only (20 vs 48, P < 0.0001). Thirty-two RA patients were evaluated longitudinally at their first visit and 3 months after the initiation of DMARDs. Following therapy, SACRAH scores were significantly reduced from 50 to 11 (P < 0.0001).
Conclusions. The questionnaire enables the quantification of compromised hand function, stiffness and pain in OA and RA patients, and is sensitive to therapy-related changes in RA patients.
KEY WORDS: Hand function, Disease activity, Scoring questionnaire.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W Zhang, M Doherty, B F Leeb, L Alekseeva, N K Arden, J W Bijlsma, F Dincer, K Dziedzic, H J Hauselmann, P Kaklamanis, et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT Ann Rheum Dis, January 1, 2009; 68(1): 8 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Stamm, S. Geyh, A. Cieza, K. Machold, B. Kollerits, M. Kloppenburg, J. Smolen, and G. Stucki Measuring functioning in patients with hand osteoarthritis--content comparison of questionnaires based on the International Classification of Functioning, Disability and Health (ICF) Rheumatology, December 1, 2006; 45(12): 1534 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. CHEN, C. V. GRANGER, C. A. PEIMER, O. J. MOY, and S. WALD Manual Ability Measure (MAM-16): A Preliminary Report on a New Patient-Centred and Task-Oriented Outcome Measure of Hand Function J Hand Surg Eur Vol., April 1, 2005; 30(2): 207 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Leeb, I. Andel, S. Leder, B. A. Leeb, and B. Rintelen The patient's perspective and rheumatoid arthritis disease activity indexes Rheumatology, March 1, 2005; 44(3): 360 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sautner, I. Andel, B. Rintelen, and B. F. Leeb Development of the M-SACRAH, a modified, shortened version of SACRAH (Score for the Assessment and Quantification of Chronic Rheumatoid Affections of the Hands) Rheumatology, November 1, 2004; 43(11): 1409 - 1413. [Abstract] [Full Text] [PDF]
|
|